BrightSpring Health Services, Inc. (NASDAQ:BTSG) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. increased its position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 275.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 163,618 shares of the company’s stock after purchasing an additional 120,005 shares during the period. JPMorgan Chase & Co.’s holdings in BrightSpring Health Services were worth $2,402,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. L & S Advisors Inc purchased a new stake in shares of BrightSpring Health Services in the 3rd quarter valued at approximately $1,247,000. Virtu Financial LLC purchased a new stake in shares of BrightSpring Health Services in the 3rd quarter valued at approximately $522,000. Assenagon Asset Management S.A. purchased a new stake in shares of BrightSpring Health Services in the 3rd quarter valued at approximately $1,822,000. LMR Partners LLP purchased a new stake in shares of BrightSpring Health Services in the 3rd quarter valued at approximately $493,000. Finally, HBK Investments L P raised its stake in shares of BrightSpring Health Services by 7.1% in the 3rd quarter. HBK Investments L P now owns 750,000 shares of the company’s stock valued at $11,010,000 after acquiring an additional 50,000 shares during the period.

BrightSpring Health Services Trading Up 12.6 %

NASDAQ BTSG opened at $20.89 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63. BrightSpring Health Services, Inc. has a 52 week low of $7.85 and a 52 week high of $21.34. The stock has a market capitalization of $3.64 billion and a PE ratio of -80.35. The firm has a 50 day moving average of $18.19 and a two-hundred day moving average of $15.36.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.07). BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The firm had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.72 billion. The company’s revenue was up 28.8% on a year-over-year basis. As a group, research analysts expect that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on BTSG shares. BTIG Research boosted their price target on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. CJS Securities began coverage on shares of BrightSpring Health Services in a research note on Thursday, December 12th. They issued an “outperform” rating and a $27.00 price target on the stock. Mizuho upped their target price on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Morgan Stanley upped their target price on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Finally, UBS Group upped their target price on shares of BrightSpring Health Services from $16.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $18.65.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.